Biomedical conventions and regulatory objectivity: A few introductory remarks

Social Studies of Science

Volumn 39, Issue 5, 2009, Pages 651-664

  Cambrosio, Alberto ^a   Keating, Peter ^b   Schlich, Thomas ^a   Weisz, George ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Biomedicine; Conventions; Objectivity; Regulation; Standardization

Indexed keywords

EID: 70349735986     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/0306312709334640     Document Type: Article

References (59)

1. Abraham, John (2002) Progress, Innovation and Regulatory Science in Drug Development, Social Studies of Science 32: 337-69.
2. Baird, Davis (2004) Thing Knowledge: A Philosophy of Scientific Instruments (Berkeley, CA: University of California Press).
3. Barry, Andrew (2001) Political Machines: Governing a Technological Society (London: Athlone Press).
4. Barry, Andrew (2005) Pharmaceutical Matters: The Invention of Informed Material, Theory, Culture & Society 22: 51-69.
5. Bates, Susan E. (2008) From the Editor, Clinical Cancer Research 14: 365.
6. Batist, G. & G.A. Shinder (2008) The McGill University Department of Oncology: Structure Depicts the Shape of Evolving Knowledge, Current Oncology 15(3): 28-35.
7. Besançon, Julien & Daniel Benamouzig (2005) Administrer un monde incertain: les nouvelles bureaucraties techniques. Le cas des agences sanitaires, Sociologie du Travail 47: 301-22.
8. Bourret, Pascale (2005) BRCA Patients and Clinical Collectives: New Configurations of Action in Cancer Genetics Practices, Social Studies of Science 35: 41-68.
9. Cambrosio, Alberto, Peter Keating, Pascale Bourret, Philippe Mustar & Susan Rogers (2009) Genomic Platforms and Hybrid Formations, in P. Atkinson, P. Glasner & M. Lock (eds), Handbook of Genetics and Society: Mapping the New Genomic Era (London: Routledge): 502-20.
10. Cambrosio, Alberto, Peter Keating & Andrei Mogoutov (2008) Protocols, Regimens and Substances: The Socio-Technical Space of Anti-Cancer Drugs, in J.-P. Gaudillière & V. Hess (eds), Ways of Regulating: Therapeutic Agents Between Laboratories, Plants, Consulting Rooms, Preprint 363 (Berlin: Max-Planck-Institut für Wissenschaftsgeschichte): 175-205.
11. Cambrosio, Alberto, Peter Keating, Thomas Schlich & George Weisz (2006) Regulatory Objectivity and the Generation and Management of Evidence in Medicine, Social Science & Medicine 63(1): 189-99.
12. Castel, Patrick (2009) What's Behind a Guideline? Authority, Competition and Collaboration in the French Oncology Sector, Social Studies of Science 39(5): 743-64.
13. Daston, Lorraine (1992) Objectivity and the Escape from Perspective, Social Studies of Science 22: 597-618.
14. Daston, Lorraine & Peter Galison (1992) The Image of Objectivity, Representations 40(1): 81-128.
15. Daston, Lorraine & Peter Galison (2007) Objectivity (New York: Zone Books).
16. Elkins, James (1992) On Visual Desperation and the Bodies of Protozoa, Representations 40: 33-56.
17. European Medicines Agency [EMEA] (2004) Evaluation of Medicines for Human Use. Position Paper on Non-Clinical Safety Studies to Support Clinical Trials with a Single Microdose, EMEA, CPMP/SWP/2599/02Rev 1, 23 June.
18. Fleck, Ludwik (1979) Genesis and Development of a Scientific Fact (Chicago, IL: University of Chicago Press).
19. Fox, Renée (2003) Medical Uncertainty Revisited, in G.L. Albrecht, R. Fitzpatrick & S.C. Scrimshaw (eds), Handbook of Social Studies in Health and Medicine (Thousand Oaks, CA: Sage Publications): 409-25.
20. Greene, Jeremy A. (2007) Prescribing by Numbers: Drugs and the Definition of Disease (Baltimore, MD: Johns Hopkins University Press).
21. Hacking, Ian (1983) Representing and Intervening (Cambridge: Cambridge University Press).
22. Hogle, Linda F. (2009) Pragmatic Objectivity and the Standardization of Human Tissue Products, Social Studies of Science 39(5): 717-42.
23. Jasanoff, Sheila (2004) Ordering Knowledge, Ordering Society, in S. Jasanoff (ed.), States of Knowledge: The Co-production of Science and Social Order (London: Routledge): 13-45.
24. Jasanoff, Sheila (2005) Designs on Nature: Science and Democracy in Europe and the United States (Princeton, NJ: Princeton University Press).
25. Keating, Peter & Alberto Cambrosio (2003) Biomedical Platforms (Cambridge, MA: MIT Press).
26. Keating, Peter & Alberto Cambrosio (2009) Who's Minding the Data? Data Managers and Data Monitoring Committees in Clinical Trials, Sociology of Health & Illness 31: 325-42.
27. Knaapen, Loes & George Weisz (2008), The Biomedical Standardization of Premenstrual Syndrome, Studies in History and Philosophy of Biological and Biomedical Sciences 39: 120-34.
28. Latour, Bruno (1990) Drawing Things Together, in M. Lynch & S. Woolgar (eds), Representation in Scientific Practice (Cambridge, MA: MIT Press): 19-68.
29. Latour, Bruno & Steve Woolgar (1986 [1979]) Laboratory Life: The Construction of Scientific Facts (Princeton, NJ: Princeton University Press [London & Beverly Hills, CA: Sage Publications, 1979]).
30. Leonelli, Sabina (2009) Centralising Labels to Distribute Data: The Regulatory Role of Genomic Consortia, in P. Atkinson, P. Glasner & M. Lock (eds), Handbook of Genetics and Society: Mapping the New Genomic Era (London: Routledge): 469-85.
31. Lynch, Michael (1985) Discipline and the Material Form of Images: An Analysis of Scientific Visibility, Social Studies of Science 15: 37-66.
32. Lynch, Michael, Simon A. Cole, Ruth McNally & Kathleen Jordan (2008) Truth Machine: The Contentious History of DNA Fingerprinting (Chicago, IL: University of Chicago Press).
33. Marchetti, S. & J.H. Schellens (2007) The Impact of FDA and EMEA Guidelines on Drug Development in Relation to Phase 0 Trials, British Journal of Cancer 97: 577-81.
34. Marks, Harry M. (1998) The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990 (Cambridge: Cambridge University Press).
35. Mol, Annemarie (2002) The Body Multiple: Ontology in Medical Practice (Durham, NC: Duke University Press).
36. Moreira, Tiago, Carl May & John Bond (2009) 'Regulatory Objectivity in Action: Mild Cognitive Impairment and the Collective Production of Uncertainty', Social Studies of Science 39(5): 665-90.
37. Nachi, Mohamed (2006) Introduction à la sociologie pragmatique (Paris: Armand Colin).
38. Patlak, Margie & Sharyl Nass (2008) Improving the Quality of Cancer Clinical Trials (Washington, DC: National Academies Press).
39. Pinch, Trevor (1985), Towards an Analysis of Scientific Observation: The Externality and Evidential Significance of Observational Reports in Physics, Social Studies of Science 15: 3-36.
40. Rabeharisoa, Vololona & Pascale Bourret (2009) Staging and Weighting Evidence in Biomedicine: Comparing Clinical Practices in Cancer Genetics and Psychiatric Genetics, Social Studies of Science 39(5): 691-715.
41. Rasmussen, Nicolas (1997) Picture Control: The Electron Microscope and the Transformation of Biology in America, 1940-1960 (Stanford: Stanford University Press).
42. Rheinberger, Hans-Jörg (1997) Toward a History of Epistemic Things: Synthesizing Proteins in the Test Tube (Stanford, CA: Stanford University Press).
43. Rheinberger, Hans-Jörg (2007) Wie werden aus Spuren Daten, und wie verhalten sich Daten zu Fakten?, in D. Gugerli, M. Hagner, M. Hampe, B. Orland, P. Sarasin & J. Tanner (eds), Nach Feierabend 2007. Daten (Zürich: Diaphanes): 117-25.
44. Ricciardi, Mario (1997) Constitutive Rules and Institutions. Paper presented at the joint meeting of the Irish Philosophical Club and the Royal Institute of Philosophy, Ballymanscanlon, February. Available at www.unipv.it/deontica/opere/riccia/rules.doc (accessed 28 February 2009).
45. Robinson, W.T. (2008) 'Innovative Early Development Regulatory Approaches: expIND, expCTA, Microdosing', Clinical Pharmacology and Therapeutics 83: 358-60.
46. Rogers, Susan & Alberto Cambrosio (2007) Making a New Technology Work: The Standardization and Regulation of Microarrays, Yale Journal of Biology and Medicine 80: 165-78.
47. Rouse, Joseph (1987) Knowledge and Power: Toward a Political Philosophy of Science (Ithaca, NY: Cornell University Press).
48. Schlich, Thomas (2000) Linking Cause and Disease in the Laboratory: Robert Koch's Method of Superimposing Visual and Functional Representations of Bacteria, History and Philosophy of the Life Sciences 22: 71-88.
49. Schlich, Thomas (2002) Surgery, Science and Industry: A Revolution in Fracture Care, 1950s-1990s (Houndsmills, Hants: Palgrave).
50. Searle, John R. (1995) The Construction of Social Reality (New York: Free Press).
51. Star, Susan Leigh & James R. Griesemer (1989) Institutional Ecology, Translations and Boundary Objects: Amateurs and Professionals in Berkeley's Museum of Vertebrate Zoology, 1907-39, Social Studies of Science 19: 387-420.
52. Strasser, Bruno J. (2006) La fabrique d'une nouvelle science. La biologie moléculaire à l'âge atomique, 1945-1964 (Florence: Olschki).
53. Strathern, Marilyn (1999) Property, Substance and Effect: Anthropological Essays on Persons and Things (London: Athlone Press).
54. Thévenot, Laurent (2009) Governing Life by Standards: A View from Engagements Social Studies of Science 39(5): 793-813.
55. Timmermans, Stefan & Marc Berg (2003) The Gold Standard. The Challenge of Evidence-Based Medicine and Standardization in Health Care (Philadelphia, PA: Temple University Press).
56. Veyne, Paul (2008) Foucault. Sa pensée, sa personne (Paris: Albin Michel).
57. Weisz, George, Alberto Cambrosio, Peter Keating, Loes Knaapen, Thomas Schlich & Virginie Tournay (2007) The Emergence of Clinical Practice Guidelines, Milbank Quarterly 85: 691-727.
58. Woolgar, Steve & Daniel Neyland (2008) Disruption, Breakdown and Resistance: Technologies of Mundane Governance, Paper presented at EGOS 2008, European Group for Organizational Studies (10-11 July, Amsterdam).
59. Zuiderent-Jerak, Teun (2009) Competition in the Wild: Reconfiguring Healthcare Markets, Social Studies of Science 39(5): 765-92.